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Abstract 
Aims & objectives: To investigate women’s awareness of chemotherapy-induced 
cognitive changes, their perception of cognitive limitations in carrying out daily tasks 
and subsequent return to work decisions and perceptions of work ability. 
Background: Evidence suggests that women diagnosed with breast cancer experience 
cognitive changes as a consequence of chemotherapy treatment. Although these 
changes tend to be subtle deficits in memory, concentration, and the ability to 
organise information, there has been no published research identifying how they can 
impact patient’s ability to work and subsequent employment decisions.  
Design: This was a qualitative study 
Method: Data were collected from breast cancer survivors using semi-structured 
interviews with two focus groups (n = 6, n = 7). Interviews were transcribed verbatim 
and analysed using Template Analysis. 
Results: Data were categorised into four main themes: 1) Awareness of cognitive 
changes during and following chemotherapy, 2) Cognitive ability and confidence in 
return to work, 3) Impact of cognitive changes on work ability, and 4) Information on 
the cognitive side effects of chemotherapy. 
Conclusion: The views and experiences of breast cancer survivors toward returning to 
work and subsequent work ability were affected by chemotherapy induced cognitive 
impairment. More specifically the appraisal of returning to work and ability to 
manage work were influenced by three interrelated factors: 1) actual cognitive ability 
following chemotherapy, 2) awareness of cognitive failures by the women and their 
families, and 3) the subsequent impact on their confidence in carrying out daily tasks 
including work tasks.  
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Relevance to clinical practice: More information and support is needed to help cancer 
patients manage chemotherapy-induced cognitive impairments within home and 
workplace. Nurses are increasingly asked about the impact of cancer and its treatment 
on work, and are therefore well positioned to offer this advice. Subsequently, nurses 
require additional knowledge and guidance to provide this information and support.  
 
Word count: 300 
 
Keywords: cognitive function, cancer, oncology, work ability, qualitative 
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BACKGROUND 
 
It is well-documented that recent advances in the detection and treatment of breast 
cancer has led to higher survival rates in women recovering from cancer (Cancer 
Research UK 2008).  As survival times increase, addressing the impact of breast 
cancer treatment on long-term outcomes such as employment have become 
progressively significant (Bradley et al. 2005). Many working-aged women surviving 
breast cancer treatment perceive returning to paid work as an important milestone in 
recovery and returning to normality (Bradley & Benareck 2002). Although some 
breast cancer patients are able to continue working during detection and treatment, or 
return to work successfully; for a significant number of women successful return to 
work is hindered by impairments due to their illness and treatment (Bradley & 
Benareck 2002; Bradley et al. 2005).  Such impairments are associated with a 
decrease in their work ability and in some cases even in disability (Chirikos et al. 
2002). 
 
Studies have associated work ability problems with the side (late) effects of 
chemotherapy, a vital feature of breast cancer treatment as it significantly contributes 
to increased survival rates (Eifel et al. 2001).  Side effects such as loss of appetite, 
hair loss, nausea, fatigue, insomnia, depression and premature menopause are well 
understood (Kaplan 1992, Schag et al. 1993, Broeckel et al. 1998, Dorval et al. 1998, 
Savard et al. 2001, Coyne et al. 2004, Massie 2004).  Importantly, cognitive side-
effects have also been linked to chemotherapy (Castellon et al. 2004, Falleti et al. 
2005, Stewart. et al 2006, Vardy et al. 2007) with growing evidence for underlying 
biological mechanisms including cytokine dysregulation (Ahles & Saykin 2007).  
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Both cross-sectional and longitudinal studies using objective measures of cognitive 
function show small to moderate impairments in cognitive function compared with 
controls or published norms.  These include language, spatial ability, verbal and 
nonverbal memory, attention and executive function (Ahles et al. 2002, Schagen et al. 
2002, Phillips & Bernhard 2003, Wefel et al. 2004, Jansen et al. 2005, Jansen et al, 
2008).  Longitudinal studies have shown that following completion of treatment there 
is improvement in cognitive function over time, although for a significant number of 
patients effects can last up to 2 years post treatment (Ahles et al. 2002, Fan et al. 
2005) and longer.  
 
Studies have examined the effects of cognitive impairments on quality of life 
(Bernhard et al. 2004, Bernhard et al. 2008, Bower 2008) but not to the same extent 
on the quality of working life (Main et al. 2005, Kennedy et al. 2007, Pryce et al. 
2007).  Questionnaire-based studies typically report the association between treatment 
(chemotherapy) and return to work outcomes (if, and when a patient returns to work), 
rather than effects of chemotherapy upon cognitive functioning and its subsequent 
impact on various work-related factors.  Studies that do report on work ability largely 
focus on the overall effects of impaired work ability or only differentiate between 
physical and mental work ability (Bradley et al. 2005, Spelten et al. 2002, Taskila & 
Lindbohm 2007, de Boer et al 2008).  Other studies have focused on fatigue related to 
chemotherapy and their effects on work performance (Messias, et al. 1997, Spelten et 
al. 2005).  A few studies have reported that those recovering from cancer experience 
difficulties in concentration, forgetfulness and speech difficulties at work (Kennedy et 
al. 2007, Pryce et al. 2007).  However, the direct impact of these on work have not 
been explored in any sufficient depth. 
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A better understanding of chemotherapy-induced cognitive side-effects on continuing 
or returning to work during/after treatment is important for patients, employers and 
health professionals involved in the treatment and management of cancer patients.   
As work plays a vital role in an individual’s economic, social and psychological 
health (Waddell & Burton 2006), studies highlight the need for cancer patients to 
receive better information from health professionals in oncology teams, general 
practice and occupational health on the effects of treatment upon working life (Pryce 
et al. 2007, Taskila & Lindbohm 2007, Amir et al., 2008).  Data suggests that 
although 62-84% of cancer patients return to work following cancer treatment, a 
significant proportion return to work with impaired work ability and are more likely 
to change or leave employment altogether (Spelten et al. 2002, de Boer et al. 2008, 
Bouknight et al. 2006). Although some treatment side effects impacting quality of 
working life have been examined (e.g. fatigue), the effects of chemotherapy on 
cognitive functioning at work are poorly understood.  It is possible that women may 
be sensitive to subtle changes in cognitive function that are not picked up by objective 
tests or through self-report questionnaires.  Awareness of such changes might 
influence women’s confidence in their ability to return to work and resume daily tasks 
(Kennedy et al. 2007).  Studies in other illness types have shown that a patient’s own 
assessment of illness and work ability do predict work outcomes (Nieuwenhuijsen et 
al. 2001, Reiso et al. 2003).   
 
The exploratory study presented in this paper sought to investigate the awareness of 
chemotherapy-induced cognitive changes among those treated for breast cancer, their 
perception of cognitive limitations in carrying out daily tasks and subsequent return to 
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work decisions and perceptions of work ability.  Breast cancer was the focus of this 
study as the majority of neuropsychological studies on cognitive functioning are 
reported on the effects of chemotherapy for breast cancer (Falleti et al. 2005), as this 
type of cancer is more likely to undergo aggressive treatment regimes (Fan et al. 
2005).  .  This study would enhance that literature as a first step to furthering our 
understanding of the impact of cognitive functioning on working life. 
 
Objectives 
a) To investigate awareness of cognitive changes following chemotherapy 
treatment. 
b) Explore perceptions of cognitive ability and subsequent confidence in carrying 
out daily tasks. 
c) Identify impact of perceptions in ability on return to work decisions and work 
ability. 
 
METHOD 
Design 
As participants were recruited via charities and support groups, rather than NHS 
clinics, NHS ethics was not sought for this study. Rather, ethics approval was 
approved by the University’s ethics committee.  Women participating in the study 
gave fully informed written consent prior to data collection. Qualitative research 
methods were used as they explore the perceptions, interpretations and beliefs of 
individuals which shape their decisions and behaviour, rather than attributing cause 
and effect (Henwood & Pidgeon 1993). 
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Data collection  
A focus group approach was taken with two groups of women who had completed 
chemotherapy treatment.  A focus group is a style of group interview comprising of 
between 6-8 participants whereby the data obtained arise from the interaction and 
discourse generated by a group discussion (Morgan 1997).  Discussion topics are 
supplied by the researcher who acts as ‘moderator’ for the discussions.  Under these 
conditions the moderator undertakes a dominant role in facilitating discussion rather 
than interviewing.  The focus group technique is well suited to the aims of this 
research where the researchers wished to elicit information on the side effects of 
chemotherapy on different aspects of cognitive functioning and the impact of these on 
different aspects of both personal and working life.  Therefore, focus groups provide 
rich and detailed qualitative data.   
 
Thirteen Women were recruited from two local support groups affiliated to a national 
cancer support charity working closely with NHS oncology clinics across the UK in 
providing information and support to those diagnosed with cancer.  The following 
inclusion criteria were applied for participation: 
 
a) Primary breast cancer diagnosis. 
b) To have completed chemotherapy (neo-adjuvant or adjuvant) between 12 
months to ten years ago.  This criteria was applied so that full information 
could be obtained with regard to employment outcomes i.e. those who 
successfully returned to work, those who encountered difficulties and those 
who had not (Kennedy 2007, Hurricane Voices Breast Cancer Foundation, 
2007). 
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c) To have been employed (≥18.5 hours per week) at time of diagnosis. 
 
Study information was disseminated to members of each support group by the group 
leader.  Women who met the inclusion criteria initially agreed to participate and met 
the researcher who explained the project details and sought written informed consent 
following a formal assessment of the inclusion criteria using a questionnaire.  
Demographic information (age, occupation, employment status, sick leave during 
breast cancer treatment) were collected at the same time.  The 25-item cognitive 
failures questionnaire (Broadbent et al. 1982)) was used to assess women’s current 
perceptions of their cognitive functioning  A total score is calculated ranging from 0 
to 100, where higher scores indicate greater cognitive impairments. 
 
Six women from one support group and seven women from the other group (total n= 
13) met participation criteria.  The same researcher facilitated both focus groups at the 
location where the support groups’ met.  Each focus group lasted 40 minutes and 
questions to facilitate each session were open ended around the following topics: 
perceptions of cognitive ability (attention, memory, problem-solving) prior to 
diagnosis and treatment; awareness of cognitive changes during and following 
treatment; impact of these changes on perception of cognitive ability (e.g. confidence 
in completing task and taking on new tasks); whether perceived changes in cognitive 
ability affected employment decisions and work ability.  The researcher used prompts 
as appropriate to encourage respondents to encourage flow of focus group interactions 
(Morgan 1997).  Both focus groups were tape recorded with permission.   
 
Analysis 
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All interviews were transcribed verbatim and analysed using template analysis 
(Crabtree & Miller 1992). According to this approach, the researcher develops a 
list of themes, the “template”, to capture the themes identified in the textual data. 
While some themes are defined a priori, subsequent interpretation of the material 
allows expansion of the themes (Crabtree & Miller 1992).  The first phase of data 
analysis involved careful reading and re-reading of all transcripts.  Initial themes 
were guided by the research questions from the focus group and the study’s 
objectives.  These themes were modified and refined as additional ones emerged 
from the data.   The second phase involved organising and subdividing the coded 
data into text segments for each emergent theme and sub-themes to aid the 
interpretive process. The data under each theme was summarised and verbatim 
quotes used to illustrate the theme being described.  The reliability of the analysis 
was ensured through systematic review of the data by three members of the 
research team.   
 
RESULTS 
Table 1 summarises the demographic profile of the participants.  All participants 
received chemotherapy. In addition, the participants also received a number of other 
related treatments such as surgery, radiotherapy and hormonal therapy.  Mean age was 
48.8 years and 43.2 years at diagnosis.  All women were in employment at the time of 
diagnosis with seven working full-time.  Eleven women took long-term sickness 
absence during treatment. Seven women reported their employment had not changed 
since diagnosis/treatment, two reduced the number of hours worked and four reported 
to have taken early retirement or left employment.  Participants reported average to 
below average cognitive functioning (mean 49.84, SD = 16.05).  Normative scores 
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range from 35.02 to 52.48 (Broadbent  et al, 1982).  Data from the focus groups are 
summarised into four main themes below. 
 
Awareness of cognitive changes during and following chemotherapy. 
 
All participants reported they had noticed some decline in their cognitive functioning 
since chemotherapy treatment.  The majority felt the effects lasted approximately a 
year or longer.  Women reported poor concentration, confusion and lack of clear 
thinking: 
 
P12: ‘It’s like a spiral isn’t it really, everything’s just sort of spiralling all the time, 
one thing to another, and concentration you can’t, your mind just wanders all 
the time’ 
P10:  ‘It felt like somebody had removed some of my brain cells… before I had 
chemotherapy my memory was reasonably good and I was good at multi-
tasking and things like that and I can definitely say that from the minute I took 
chemo, my brain just went into a fog.’ 
 
Problems associated with concentration and divided attention affected women’s 
ability to communicate with more than one person at any one time: 
 
P11:   ‘I remember having more than one person speaking to me at once, even when 
they would come round to the house, if I had two or three people, I found that 
really difficult to cope with because I felt as though they were just doing this’ 
(makes duck hand gesture). 
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Many of the women felt frustrated at their incapacity to function as effectively as they 
could prior to treatment. This was especially apparent with regard to multi-tasking 
and decision making on a daily basis: 
 
P8: ‘I go shopping and I spend five minutes looking at each product going: 
“Which one do I want?” 
P9: ‘Well I’ll go: “For goodness sake”, and I’ll walk away, and I’ll go home and  
I’m like well I don’t know what we are going to have for tea because I was in  
the shop but I couldn’t make my mind up.’ 
 
In addition to poor cognitive functioning, the women felt their ability to cope with 
problems has also declined significantly following chemotherapy: 
 
P10: ‘I don’t know if this is the same for any of you, but I found that before 
treatment I used to have quite a high stress level, I can’t deal with too much 
stress anymore.’ 
P7: ‘ No, I can’t.’ 
P10:  ‘There will be a couple of things, and I kind of switch off, I just can’t deal with   
it.’ 
 
As some of the women were receiving or had received other treatments (e.g. 
tamoxifen) they were asked whether they felt some of the cognitive changes were 
associated with these treatments.  All women reported they were mostly aware of 
cognitive changes when chemotherapy started and most reported they did not feel 
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subsequent treatments had further impaired, changed or improved their cognitive 
functioning. 
 
Cognitive ability and confidence in return to work 
 
All women discussed how their cognitive impairments negatively affected their self-
confidence in their cognitive ability.  Women reported worrying about appearing slow 
or incapable, largely due to how family members responded to the changes.  Family 
members often made comparisons between their cognitive problems and types of 
dementia: 
 
P5: ‘I repeat myself that many times my husband says: “Have you got 
Alzheimer's?” yeah and it’s since I had treatment last year I repeat myself 
atrociously’ 
 
P10:  ‘I do remember when I was on the chemo, I’d ask the children something and 
then ten minutes later I would ask them the same thing again and they would 
say: “What is the matter with you, are you losing the plot?” and I would 
swear blind I hadn’t asked the question and they hadn’t answered me.’ 
 
Being aware of memory problems meant that many women felt unconfident in 
interacting with others in fear of their memory failing as one woman discussed: 
 
P9: ‘Sometimes my husband would say: “You’re being very quiet”, which is 
unusual for me and I’d sort of say yes, and then I wouldn’t say anything and 
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then a bit later on I’d end up telling him I just wasn’t sure whether I’d told 
you something and I didn’t want to say it again if I had.’ 
 
With regard to employment, although most women were keen to return to work for a 
sense of ‘normality’ they felt negative about their cognitive ability and how it would 
affect them in carrying out daily work tasks.  This was irrespective of being in a 
manual or non-manual job.  They felt returning to work further emphasised their 
cognitive impairments and their confidence in their work ability.  This led to concerns 
of not meeting employer expectations upon returning to work:   
 
P9:  ‘It was when I went back to work I noticed, I felt as though I’d had a 
 lobotomy.’ 
P11:  ‘Yeah, I was having to use my brain in a completely different way to the ten 
months I’d spent at home’. 
P13:  ‘It doesn’t matter at home does it, if you forget things, it really doesn’t 
 matter.’ 
P11:  ‘No it’s not the same I don’t think, I wasn’t really aware until I went back to   
  work…so that affects your confidence and your competence and your ability 
 to know   whether you actually can do your job.’ 
 
One woman found alternative employment following recovery.  This increased her 
confidence in her cognitive skills despite the problems, as her new employer and 
colleagues had no prior expectations of her cognitive abilities: 
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P13: ‘I started a new job and what I found was that I did have a lot of confidence 
because nobody knew me, so nobody knew what I was capable of, what I did 
before a hundred years ago and I started from scratch. So for me I was like, 
I’ve done chemo so I can take on the world, so I was very different, no I 
honestly think it would have been a totally different story had I gone back to 
the original working environment, I think I would have felt very conspicuous, 
it think it would have jumped out haha, I haven’t got a clue what I’m doing!’ 
 
Despite problems with cognitive functioning, those women who felt supported at 
work by their employer and their colleagues, reported feeling less daunted about 
returning to work and more confident in completing work tasks: 
 
P6:   ‘Now I’m back at work they’ve got me an assistant for six weeks to help me, 
which I think is really good. The support has been first class.’ 
 
One woman discussed feeling uncertain about her employability since chemotherapy 
treatment due to the detrimental cognitive side effects.  This lead to difficulties in 
deciding whether she was able to return to work.  
 
P3: ‘I’m not back at work yet and my doctor said that I don’t think that you will go 
back to that job. She said that you’ve got very low employability at the minute, 
I don’t particularly want to go back to that job anyway, but I think well, what 
am I going to do, I just live from one month to the next, I’m in a bit of a 
nowhere land really, I can’t plan anything I just get on with it.’ 
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Impact of cognitive changes on work ability 
 
All women experienced cognitive-side effects at work and which they felt were 
related to their chemotherapy treatment.  These had a negative effect on their work 
performance with problems lasting up to a year post return to work.  Most felt 
overwhelmed by their work environment and in some cases found the work 
environment unbearable.  Noise was a key factor that impacted on women’s cognitive 
function and subsequently affected their ability to perform at work: 
 
P12: ‘When I went back to work, it was in a factory and it was really, really noisy, 
but it was like, there was no noise in particular it was just one noise, it was 
like your head’s swimming, it’s just noise, it’s just all going on but there’s no 
particular thing, no particular talking or voice or something it’s just all one. 
And your head’s just going like that (makes funny face). I remember going 
back to work and thinking: “Oh I just want to get out of here, I can’t stand 
this, all the noise and everything”, it was awful it’s weird.’ 
 
The women reported that poor concentration, memory problems and difficulties in 
thinking quickly since chemotherapy has had a negative effect on specific aspects of 
their job: 
 
P6: ‘I found it very difficult to concentrate at work and I mean I read thing over 
and over again and then I’m thinking, what was all that about and just have to 
start again, so I am finding that more difficult than before any treatment.’ 
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P9: ‘I can vaguely recall thinking something, well I wasn’t sure if I thought it or 
said it, and then I wouldn’t say it because I wouldn’t remember whether I’d 
already said it, and I didn’t want to appear to be repeating myself.’ 
 
P12: ‘You just can’t keep up with it can you, it’s just too fast, to demanding to sort 
of keep that pace up.’ 
 
They also reported problems with organising information and decision-making. 
Although some women discussed fatigue affecting cognitive functioning, the majority 
felt that the effects were largely independent of that.  Many felt that their performance 
was below their standard prior to chemotherapy as one woman described: 
 
P11:  ‘All people wanting me to make all these decisions and it was almost like I’d 
got this old tin bin (brain) and I was just putting stuff in there and I felt as if 
the lid was going to fly off and everything explode, I couldn’t cope with it, I 
felt as though it was like that in the early stages of going back to work.’ 
 
As a result, a number of women hid their cognitive difficulties from their employer 
rather than discussing them: 
 
P11:  ‘It’s about having to make decisions at work, and it took me I would say a 
good two months before I felt my brain was starting to operate how it should 
do, but I just thought, I just felt as though I had become a completely different, 
inept person, and they were going to find me out!’ 
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Information on the cognitive side effects of chemotherapy 
 
All women reported receiving insufficient information regarding the cognitive side-
effects of chemotherapy from their oncology team or support groups.  No verbal or 
written information was given by the clinics on the cognitive-side effects of 
chemotherapy.  A few of the women had leaflets from major charities or support 
groups that briefly outlined some of the cognitive effects but the women felt this was 
not in any detail.  It was strongly felt that more information could have helped women 
understand the changes better and adjust to them more effectively, particularly with 
regard to returning to, and maintaining work, as one woman summarised: 
 
P8: ‘Reassurance as well, that actually, this could be expected or this has been 
reported, sometimes I just think I might be going off my head and if I was told 
‘this was normal to experience’ that would help.’ 
 
DISCUSSION 
Findings from this study indicate that women treated for breast cancer report 
experiencing cognitive impairments that affect their working life.  The cognitive 
problems experienced by these women range from short-term memory problems, 
verbal ability, speed of processing information and executive functioning (multi-
tasking, making decisions and dividing attention).  These findings are consistent with 
the extant literature on objective measures of cognitive functioning in breast cancer 
patients (Falleti et al. 2005, Stewart et al. 2006) and other studies reporting the side-
effects experienced by those receiving chemotherapy (Hurricane Voices Breast 
Cancer Foundation, 2007).  Women in this study reported that problems with 
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memory, concentration, decision-making and multi-tasking affected their views and 
experiences toward returning to work, and subsequent work ability.  
 
Interestingly, the women’s appraisal of returning to work and managing work were 
influenced by three interrelated factors: actual cognitive-side effects following 
chemotherapy, awareness of cognitive failures by the women and their families; and 
the subsequent impact on their confidence in carrying out daily tasks including work 
tasks.  The influence of family members on the women’s self-confidence in their 
cognitive abilities is a similar finding to that reported by Visser, et al. (2004). They 
report that family members were often indirectly affected by chemotherapy treatment.  
They report tension between family members who are frustrated that the 
chemotherapy recipient can no longer function in the same way prior to treatment.  
Taken together, the findings from this study and that of Visser et al. (2004), indicate 
that women who are aware of family members affected by their cognitive 
impairments, might anticipate continuing to experience such problems when they 
return to work; thus lowering their confidence and heightening their awareness and 
anxiety of cognitive problems upon returning to work. 
 
The potential role of women’s confidence in their cognitive abilities suggests that 
self-efficacy (Bandura 1997) maybe an important psychological mechanism 
influencing perceptions of cognitive ability and subsequent cognitive function.  This 
concept requires further exploration and study as it could have important implications 
for interventions.  Although the objectives of this study did not include exploring 
avenues for intervention, the focus group gave the women the opportunity to discuss 
the need for better healthcare information and support to enable them to effectively 
 20
manage and cope with their cognitive changes.  This is supported by a study by 
Ferguson et al. (2007) who found that training women in self-awareness and cognitive 
compensatory strategies helped to recompense for cognitive problems such as 
memory problems.  As the women in this study reported that confidence in their 
cognitive skills was an issue particularly with regard to returning to, and maintaining 
work, it is important that this aspect is incorporated into any intervention and 
evaluated.  Overall, further research is required into what cancer patients needs are in 
relation to information, support and appropriately tailored intervention; and what 
oncology teams and other healthcare specialists feel they are proficient in delivering. 
 
In terms of cognitive impairments affecting work ability, women in this study 
reported struggling with short-term memory, concentration, multi-tasking, thinking 
quickly and making decisions. Again this profile is consistent with studies on 
cognitive functioning.  Interestingly, many of the women tried to hide their cognitive 
problems from their employers even though they struggled with their work and could 
have benefited from support or assistance.  Studies have documented the problems 
associated with the effects of chemotherapy on cancer patients’ general work ability 
but have not detailed these effects in terms of specific cognitive problems upon 
different job types (Kennedy  et al. 2007, Pryce  et al. 2007, Taskila & Lindbohm 
2007). This study significantly contributes to this literature in two important ways: 
first, it highlights specific aspects of cognitive functioning that affect women in both 
manual and non-manual jobs alike; and second, these findings are directly based on 
these women’s perspectives and experiences and which they believe affect their work 
performance.  More objective measures may not necessarily detect the impact of these 
cognitive affects which may only become more apparent when women return to work 
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and resume work tasks.  Indeed, it is well documented that there are no significant 
correlations between subjective perceptions of cognitive and objective 
neuropsychological measures (Castellon et al. 2004).  This raises a concern that 
neuropsychological measures do not take into account the environment within which 
the individual is situated and interacts with, such as the workplace.  As women in this 
study highlight, there is need for more information on chemotherapy-induced 
cognitive impairment, particularly with regard to returning to, and maintaining work.  
Healthcare professionals involved in the treatment and care of cancer patients are in a 
prime position to provide more informative prognosis on chemotherapy-induced 
cognitive impairments for both patients, their families and their employers (Kennedy 
et al. 2007, Pryce et al. 2007 , Amir et al. 2008).  
 
Several limitations must be considered. The findings must be interpreted with caution 
as the participants were recruited from support groups rather than directly from clinics 
and were a small sample size.  Therefore, their views may not be fully representative 
of the general population of women diagnosed with breast cancer.  Further research is 
required using a larger and more representative sample to substantiate our findings.  A 
number of women were aged over forty at the time of diagnosis. Women in later life 
are reported to experience some decline in their cognitive abilities due to ageing 
(Weuve et al. 2004).  Moreover, menopausal status may have contributed towards the 
cognitive changes experienced (Jansen, 2008). As suggested by Love et al. (1988), it 
is not possible to attribute all cognitive changes reported to chemotherapy alone, as 
there are many other variables and treatments that could contribute to these changes. 
Although a number of studies suggest that fatigue plays a pivotal role in cognitive 
functioning in cancer patients receiving cancer treatment, this study found that women 
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reported cognitive problems directly related to chemotherapy.  While a couple of the 
women discussed the effects of fatigue of cognitive functioning, the women felt these 
were additional problems.  This finding is consistent with more objective studies of 
cognitive functioning that control for the effects of fatigue (e.g. Jansen, 2008).  
 
CONCLUSION 
This study provides some important insights into the experiences of women managing 
the impact of chemotherapy-induced cognitive impairments upon working life.  This 
issue has not been previously explored in sufficient depth.  This study provides a 
starting point for further qualitative research comparing the different aspects of the 
work environment upon cognitive functioning, supported by quantitative data, which 
would strengthen data interpretability.  The study also highlights the need for more 
information and support to help cancer patients manage the chemotherapy-induced 
cognitive impairments within the home environment and especially at work, which 
plays a pivotal role in the physical, psychological, and social recovery of cancer 
patients. 
 
RELEVANCE TO CLINICAL PRACTICE 
Nurses are well positioned to offer advice to patients on the impact of cancer 
treatment on work ability. It is important for nurses to identify and better understand 
how treatment can impact cognitive functioning and subsequently work ability. 
Nurses can help to develop effective interventions that enable cancer patients to use 
strategies that maintain and improve their cognitive functioning during and post 
treatment.  Future work will focus on developing appropriate interventions. 
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Table 1. Participant Demographics (n = 13) 
 
 * Participant number 
S, surgery; C, chemotherapy; R, radiotherapy; H, hormonal therapy; MA, monoclonal antibodies 
  CFQ = Cognitive Failures Questionnaire
*Pp Age 
(years)  
 
Age at  
diagnosis 
(years) 
 
Treatment Other chronic 
illnesses 
Occupation Work  
status  
Hours/
week 
Work  
Changes 
>4 weeks 
sick leave  
CFQ 
1 60 57 S, C, R& MA None Clerical assistant Full-time 37 None No 41 
2 56 52 S, C & R None Head of department Full-time 70 Retired Yes 85 
3 36 34 R, C, & H None Financial accountant Full-time 42 None Yes 31 
4 48 46 C, S & R None Administrator Full-time 35 None Yes 28 
5 45 37 S, O, C & R None Shop assistant Part-time 19 None Yes 61 
6 49 48 C, S, R & H None Professional standards officer Full-time 37 Reduced hours Yes 36 
7 52 46 S, C, R, & H None Warehouse operator Part-time 30 None Yes 44 
8 48 39 S, C, R & H None Operations director Full-time 40.5 Stopped work Yes 37 
9 51 45 S, C, H None Senior receptionist & financial manager Part-time 21 None No 60 
10 48 46 S, C, MA & R None Medical secretary & counsellor Part-time 3 Reduced hours Yes 60 
11 53 40 S, C & R None MR manager Full-time 37 Retired Yes 64 
12 49 40 C, R, & S None Warehouse packer Part-time 20 None Yes 47 
13 39 32 S, C, R & H None Hairstylist Part-time 18.5 Stopped working Yes 54 
 
